Job cuts at the National Institutes of Health have left many cancer patients in limbo as they wait on their specialized treatment to be completed, The Washington Post reported June 18.Here’s what to know:1. As of April, the production of specialized immune-cell therapies for metastatic cancer patients was delayed due to NIH staff cuts that […]
